MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
exercise of warrants
$3,908K
Net cash provided by
financing activities
$3,363K
Canceled cashflow
$545K
Net decrease in
cash, cash...
-$190K
Canceled cashflow
$3,363K
Accrued compensation
and benefits
$429K
Recurring fair value
measurements of liabilities
-$332K
Stock-based compensation
and related charges
$90K
Non-cash operating lease
expense
$22K
Depreciation
$1K
Payment of warrant
inducement issuance costs
$445K
Payments on insurance
financing debt
$100K
Net cash used in
operating activities
-$3,553K
Canceled cashflow
$874K
Net loss
-$2,868K
Accounts payable and
accrued liabilities
-$955K
Prepaid and other
current assets and other...
$519K
Other
$61K
Operating lease
liabilities
-$24K
Back
Back
Cash Flow
source: myfinsight.com
PALISADE BIO, INC. (PALI)
PALISADE BIO, INC. (PALI)